Your browser doesn't support javascript.
loading
An evidence-based terlipressin therapy for gastroesophageal variceal hemorrhage / 中华肝脏病杂志
Zhonghua ganzangbing zazhi ; Zhonghua ganzangbing zazhi;(12): 245-248, 2018.
Article in Zh | WPRIM | ID: wpr-806386
Responsible library: WPRO
ABSTRACT
Gastroesophageal variceal bleeding is one of the major complications of cirrhosis and also the leading causes of death in patients with decompensated cirrhosis. Terlipressin is a triglycyl-lysine vasopressin, a synthetic vasopressin analogue that is mainly used for the treatment of acute variceal hemorrhage. This article aims to review the current status of treatment of gastroesophageal variceal bleeding with terlipressin from the perspective of evidence-based medicine.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Zhonghua ganzangbing zazhi Year: 2018 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Zhonghua ganzangbing zazhi Year: 2018 Type: Article